Quarterly results round-up: COV gets off to flying FY13 start; GETIB's medical systems boasts strong top-line for Q4
This article was originally published in Clinica
Executive Summary
Covidien started its new fiscal year with a strong first quarter, beating analysts' expectations with robust top-line growth from its medical devices business.